ISSN: 0973-7510

E-ISSN: 2581-690X

Maged S. Ahmad1, Manal M. Yasser1 and Essam N. Sholkamy1,2
1Department of Botany, Faculty of Science, University of Beni-Suef, Beni-Suef – 62511, Egypt.
2Department of Botany and Microbiology, College of Science, King Saud University,
P. O. Box 2455, Riyadh 11451, Saudi Arabia.
J Pure Appl Microbiol. 2014;8(1):251-262
© The Author(s). 2014
Received: 11/10/2013 | Accepted: 26/12/2013 | Published: 28/02/2014
Abstract

In the current study, Streptomyces bikiniensis was isolated from insect (Tapinoma simrothi), Riyadh, Saudi Arabia, and identified by classical and molecular methods. The biosynthesized silver nanoparticles (AgNPs) were characterized by determining Fourier transform infrared spectroscopy (FTIR), Energy Dispersive Spectroscopy (EDS) and transmission electron microscopy (TEM). TEM photos of nanoparticles showed the spherical shapes of nanoparticles in the size range of 3–70 nm. Moreover, the minimum inhibitory concentration of biosynthesized silver nanoparticles against Staphylococcus aureusStreptococcus pyogenes, Klebsiella pneumonia, Pseudomonas aeruginosa and Salmonella typhi were at 8 µg per paper disc (6 mm), and the inhibition zones were 7 to 9 mm while was at 16µg per paper disc in case of Candida albicans, the inhibition zone was 8 mm. The lethal inhibitory concentration (IC50) of AgNPs on Hep2 and MCF-7 cells was obtained at 253.6 and 119.6 µg/ml, respectively. Thus, bioconversion of silver nanoparticles by Streptomyces bikiniensis strain Ess_amA-1 can be employed as a potential Nano-drug to kill pathogenic microbes.

Keywords

Silver nanoparticles, Streptomyces, SEM, IC50

Article Metrics

Article View: 657

Share This Article

© The Author(s) 2014. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.